Julie, watching Epidemiology I-Min Symposium

EPI Seminar Series

Epidemiology Seminars

Event Information for Harvard T.H. Chan School of Public Health’s:

PGSG Spring Seminar Series Schedule
ID Epi Spring Seminar Series and Events

Spring 2015 Department Seminars:


David Wilson
March, 11th | Kresge 502
Global HIV/AIDS Program Director
Health, Nutrition and Population Global Practice, World Bank
Can We End AIDS: Perspectives to Consider

Mei Sheng Duh
Mei Sheng Duh, MPH, ScD

March, 4th | Kresge 502
Managing Principal (Partner) Chief Epidemiologist, Analysis Group, Inc., Boston

Pharmacovigilance and Social Media Data


Elsie Freeman Epi Speaker Series

Elsie Freeman, MD, MPH
February, 25th | Kresge 502
Senior Research Fellow, Muskie School, University of Southern Maine

The Interdependence of Health Rist, Chronic Disease and Mental Illness


Monique Breteler-Epi Seminar

Monique M.B. Breteler, MD, PhD

February 18th
12:30-1:30pm | Kresge 502
Director of Population Health Sciences, German Center for Neurodegenerative Diseases(DZNE);
Professor of Population Health Sciences, University of Bonn, Germany;
Adjunct Professor of Epidemiology, Harvard T.H. Chan School of Public Health
The Rhineland Study: A Novel Cohort for Population based Research on Brain, Body and Behavior

JoAnn Manson

JoAnne E. Manson, MD, DrPH, FACP, FACE

February 11th
12:30-1:30 | Kresge 502
Professor of Medicine and the Michael and Lee Bell Professor of Women’s Health, HMS
Professor, Department of Epidemiology, Harvard T.H. Chan School of Public Health
How VITAL is Vitamin D: Is Enthusiasm Outpacing the Evidence?


David Siscovick - Epi Seminar Series
David Siscovick, MD, MPH

February 4th
12:30-1:30pm | Kresge 502
Senior Vice President for Research
The New York Academy of Medicine
Strategic Transformation of a Clinical Cardiovascular Epidemiologist: Back to the Future



Michelle D. Holmes, MD, DrPH

January 28th
12:30-1:30pm | Kresge 502
Assoc. Prof. of Medicine & Epidemiology
Harvard Medical School & Harvard T.H Chan School of Public Health
Hiding in plain view: the need for a randomized trial of aspirin for breast cancer survival



John P.A. Ioannidis, MD, DSc

January 7th
12:30-1:30pm | Kresge 502
C.F. Rehnborg Chair in Disease Prevention
Professor of Medicine, of Health Research and Policy, and of Statistics.
Director, Stanford Prevention Research Center(SPRC
Co-Director, Meta-Resarch Innovation Center(METRICS), Stanford University
Exposure-wide Association Studies